1Humphrey PA, Vollmer RT. Relationships between serum proslate-specific antigen and histopathologic appearances of prostate carcinoma. In: Foster CS, Bostwick DG, editors. Pathology of Prostate. London: W. B. Saunders Company; 1998.p253-81.
2Harada M, Nemoto R, Uchida K, Akaza H, Koiso K, Mostofi FK. Histopathological comparison of prostatic adenocarcinoma in Japan and the United States. Nippon Hinyokika Gakkai Zasshi 1993; 84:1110-18.
3Humphrey PA, Keetch DW, Smith DS, Shepherd DL, Catalona WJ. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. J Urol 1996; 155: 816-20.
4Bostick DG, Dundore P. Biopsy Pathology of the Prostate.New York: Chapman & Hall Medical; 1997. p141-63.
5Rigley JR, Bullock M, Amin M. Small glandular patterns in the prostate: differential diagnosis of small acinar carcinoma.In: Foster CS, Bostwick DG, editors. Pathology of Prostate.London: W. B. Saunders Company; 1998. p126-55.
6Shirley SE, Escoffery CT, Sargeant LA, Tulloch T. Clinicopathological features of prostate cancer in Jamaican men. BJU Int 2002; 89: 390-5.
7Catalona W J, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151: 1283-90.
8Hoedemaeker RF, van der Kwast TH, Boer R, de Koning HJ,Roobol M, Vis AN, et al. Pathologic features of prostate cancer found at population-based screening with a four-year interval. J Natl Cancer Inst 2001; 93:1153-8.
